Spaces:
Running
on
Zero
Running
on
Zero
Adjust the text format
Browse files
app.py
CHANGED
@@ -61,11 +61,11 @@ description_md = """
|
|
61 |
## π **About AllerTrans β A Powerful Tool for Predicting the Allergenicity of Protein Sequences**
|
62 |
|
63 |
###### **𧬠Input Format β FASTA Sequences:** This tool accepts protein sequences in FASTA format.
|
64 |
-
|
65 |
-
###### **π§Ύ Output Explanation** β AllerTrans classifies your input sequence into one of the following categories
|
66 |
-
|
67 |
-
|
68 |
-
|
69 |
###### **π Caution & Disclaimer:** Our model has demonstrated promising performance on the AlgPred 2.0 validation set, which includes a wide range of allergenic and non-allergenic sequences from diverse sources. AllerTrans is also capable of handling recombinant proteins, as supported by additional evaluation using a recombinant protein dataset from UniProt. However, **we advise caution when using this tool on all constructs and modifications of recombinant proteins**. The model's generalizability across various recombinant scenarios has yet to be fully explored.
|
70 |
|
71 |
###### π¨ Remember, AllerTrans is designed as a reliable screening tool. However, for clinical or regulatory decisions, always confirm the prediction results through experimental validation.
|
|
|
61 |
## π **About AllerTrans β A Powerful Tool for Predicting the Allergenicity of Protein Sequences**
|
62 |
|
63 |
###### **𧬠Input Format β FASTA Sequences:** This tool accepts protein sequences in FASTA format.
|
64 |
+
<br>
|
65 |
+
###### **π§Ύ Output Explanation** β AllerTrans classifies your input sequence into one of the following categories:
|
66 |
+
###### **π’ Non-Allergen:** The protein is unlikely to cause an allergic reaction and can be considered safe regarding allergenicity.
|
67 |
+
###### **π΄ Potential Allergen:** The protein has the potential to trigger an allergic response or exhibit cross-reactivity in some individuals.
|
68 |
+
<br>
|
69 |
###### **π Caution & Disclaimer:** Our model has demonstrated promising performance on the AlgPred 2.0 validation set, which includes a wide range of allergenic and non-allergenic sequences from diverse sources. AllerTrans is also capable of handling recombinant proteins, as supported by additional evaluation using a recombinant protein dataset from UniProt. However, **we advise caution when using this tool on all constructs and modifications of recombinant proteins**. The model's generalizability across various recombinant scenarios has yet to be fully explored.
|
70 |
|
71 |
###### π¨ Remember, AllerTrans is designed as a reliable screening tool. However, for clinical or regulatory decisions, always confirm the prediction results through experimental validation.
|